UroGen Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	110.75	171.99	95	55.41	44.36
Short-Term Investments	9.71	64.7	41.97	44.56	44.78
Cash & Short-Term Investments	120.46	236.69	136.97	99.96	89.14
Cash Growth	-49.11%	72.80%	37.02%	12.14%	-12.62%
Accounts Receivable	33.08	20.3	15.44	12.7	11.72
Inventory	16.46	9.23	5.67	4.33	4.83
Other Current Assets	16.02	9.92	11.1	11.91	8.7
Total Current Assets	186.02	276.14	169.19	128.91	114.39
Net Property, Plant & Equipment	9.09	3.79	2.36	3.75	3.15
Long-Term Investments	-	5.02	4.5	-	0.68
Other Long-Term Assets	5.34	0.77	2.26	2.96	1.53
Total Assets	200.46	285.71	178.31	135.62	119.75
Accounts Payable	27.72	27.43	16.54	12.38	12.1
Accrued Expenses	13.52	10.57	10.81	8.26	6.95
Other Current Liabilities	5.19	7.95	3.86	3.28	3.33
Total Current Liabilities	46.42	45.95	31.21	23.92	22.38
Long-Term Debt	122.21	121.73	98.55	97.54	-
Long-Term Leases	6.12	1.65	0.84	1.59	0.4
Other Long-Term Liabilities	131.18	125.18	112.92	101.94	88.56
Total Long-Term Liabilities	259.51	248.57	212.31	201.06	88.95
Total Liabilities	305.93	294.51	243.52	224.98	111.33
Common Stock	0.13	0.12	0.09	0.06	0.06
Additional Paid-in Capital	854.09	797.25	614.04	487.79	475.7
Accumulated Other Comprehensive Income	0.02	0.06	0.01	-0.11	-0.03
Retained Earnings	-959.72	-806.22	-679.35	-577.1	-467.32
Shareholders' Equity	-105.47	-8.8	-65.21	-89.36	8.41
Total Liabilities & Equity	200.46	285.71	178.31	135.62	119.75
Total Debt	128.33	123.39	99.4	99.12	0.4
Net Cash (Debt)	-7.88	113.3	37.57	0.84	88.74
Net Cash Growth	-	201.54%	4367.66%	-99.05%	-11.72%
Net Cash Per Share	-0.16	2.64	1.30	0.04	3.97
Book Value	-105.47	-8.8	-65.21	-89.36	8.41
Book Value Per Share	-2.19	-0.21	-2.26	-3.92	0.38
Tangible Book Value	-105.47	-8.8	-65.21	-89.36	8.41
Tangible Book Value Per Share	-2.19	-0.21	-2.26	-3.92	0.38

Updated Mar 2, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q